Robert Snyder, DPM, MSc, MBA, CWSP, discusses the epidemiology of diabetic foot. Dr Snyder also lists the differences between acute and chronic wound biochemistry, discusses the use and mechanism of action of autologous blood clot tissue wound matrix to accelerate wound healing.
Robert Snyder, DPM, MSc, MBA, CWSP
Dean, School of Podiatric Medicine
Professor and Director of Clinical Research
Director, Fellowship Program in Wound Care and Research
Barry University School of Podiatric Medicine
To view Lectures online, the following specs are required:
It is the policy of PRESENT e-Learning Systems and it's accreditors to insure balance, independence, objectivity and scientific rigor in all its individually sponsored or jointly sponsored educational programs. All faculty participating in any PRESENT e-Learning Systems sponsored programs are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts.---
Robert Snyder Has disclosed that he received Honorarium/Expenses from and is an advisor/consultant for Johnson & Johnson and Pfizer.